Maxime Dely: Sickle Cell Disease – Behind Every Exchange, There Is a Donor
Maxime Dely, Therapeutic Solutions Sales Consultant at Terumo Blood and Cell Technologies, shared a post on LinkedIn:
“Sickle cell disease: Behind every exchange, there is a donor.
Sickle cell disease sometimes requires automated red blood cell exchange, an impressive technology that helps reduce hemoglobin S and improve patient care.
But this technology depends on one essential resource: compatible blood.
Repeated transfusions carry a risk of alloimmunization when transfused red blood cells carry antigens that differ from those of the patient.
This is why specific blood phenotypes are required.
Yet these blood profiles are now particularly rare in blood supplies.
As a result, an exchange that would ideally require 6 red blood cell units may sometimes have to be performed with 5 or 4, potentially reducing its effectiveness and requiring more frequent procedures.
Access to automated apheresis is a major medical advance. But without compatible blood, it cannot reach its full potential.
So let’s mobilize: donate blood and help raise awareness of this critical need.
Behind every blood unit, there is a donor, a patient, and the possibility of receiving the treatment they need.
Donating blood can make treatment possible.”

Other posts featuring Maxime Dely on Hemostasis Today.
-
Nov 21, 2026, 20:00Jeyda Star: The FAST Signs of Stroke and the Reality of Life Afterward
-
Nov 21, 2026, 19:59Daniel Lindholm: Women Showed the Largest Improvement in Stroke Risk Over Time in Heart Failure
-
Nov 21, 2026, 19:56Neil Arrowsmith: Raising Awareness of Pulmonary Embolism in Young People
-
Nov 21, 2026, 19:52Muhammad Zeeshan Jamal: Thrilled to Present Our Research on Intermediate-Risk Acute PE in Abu Dhabi
-
Nov 21, 2026, 19:50Mounisha Devireddy: Proud to Share Our Research on High-Risk PE in Pregnancy
-
Nov 21, 2026, 19:47Melissa Hollo: How Severe Anemia Increases the Odds of Acute HF During Pregnancy and Postpartum
-
Nov 21, 2026, 19:44Ashenafi Tazebew Amare: Building Sustainable Systems to Close the Anti-D Immunoglobulin Access Gap in LMICs
-
Nov 21, 2026, 19:43Sheharyar Raza: Interpreting Clotting Times Through Reptilase Time and Thrombin Time Assays
-
Nov 21, 2026, 19:42Minoo Ahmadinejad: Serving on the ISTH 2027 Scientific Theme Committee for Women’s Health